+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Advanced Therapy Medicinal Products CDMO Market by Products (Cell Therapy, Gene Therapy, Tissue Engineered), Phase (Phase I, Phase II, Phase III), Indication, End-Users - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5665766
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Advanced Therapy Medicinal Products CDMO Market size was estimated at USD 7.54 billion in 2023, USD 8.74 billion in 2024, and is expected to grow at a CAGR of 17.06% to reach USD 22.74 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Advanced Therapy Medicinal Products CDMO Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Advanced Therapy Medicinal Products CDMO Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Advanced Therapy Medicinal Products CDMO Market, highlighting leading vendors and their innovative profiles. These include Abzena, Advanced Therapies, Inc. by WuXi AppTec, AGC Inc., Aldevron, Almac Group, Arranta Bio Holdings, LLC, Bio Elpida, BlueReg, Catalent Inc., CELONIC Group, CGT Catapult, Charles River Laboratories International, Inc., Coriolis Pharma Research GmbH, Eurofins Scientific SE, FUJIFILM Corporation, Lonza Group, Minaris Regenerative Medicine, Oxford Biomedica PLC, Patheon by Thermo Fisher Scientific Inc., Rentschler Biopharma SE, REPROCELL Inc., RoslinCT, Samsung Biologics, and VIVEBIOTECH S.L.

Market Segmentation & Coverage

This research report categorizes the Advanced Therapy Medicinal Products CDMO Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Products
    • Cell Therapy
    • Gene Therapy
    • Tissue Engineered
  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Indication
    • Cardiology
    • Central Nervous System
    • Dermatology
    • Endocrine, Metabolic, Genetic
    • Gastroenterology
    • Hematology
    • Immunology & Inflammation
    • Infectious Disease
    • Musculoskeletal
    • Oncology
    • Ophthalmology
  • End-Users
    • Academic and Research Institutions
    • Biotechnology & Pharmaceutical Companies
    • Clinical Research Organizations (CROs)
    • Hospitals and Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Advanced Therapy Medicinal Products CDMO Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Advanced Therapy Medicinal Products CDMO Market?
  3. What are the technology trends and regulatory frameworks in the Advanced Therapy Medicinal Products CDMO Market?
  4. What is the market share of the leading vendors in the Advanced Therapy Medicinal Products CDMO Market?
  5. Which modes and strategic moves are suitable for entering the Advanced Therapy Medicinal Products CDMO Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Advanced Therapy Medicinal Products CDMO Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Proliferation in prevalence of rare diseases with growing emergence of novel
infectious diseases
5.1.1.2. Rising numbers of clinical trials for development of advanced therapy medicinal products
5.1.1.3. Increasing investments in pharmaceutical research and development worldwide
5.1.2. Restraints
5.1.2.1. High cost associated with outsourcing ATMP solutions
5.1.3. Opportunities
5.1.3.1. Adoption of advanced technologies by advanced therapy medicinal
products CDMOs
5.1.3.2. Strategic alliance and expansion activities for R&D of advanced therapy medicinal products
5.1.4. Challenges
5.1.4.1. Stringent governmental rules and regulations for ATMP approvals and
commercialization
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Advanced Therapy Medicinal Products CDMO Market, by Products
6.1. Introduction
6.2. Cell Therapy
6.3. Gene Therapy
6.4. Tissue Engineered
7. Advanced Therapy Medicinal Products CDMO Market, by Phase
7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III
7.5. Phase IV
8. Advanced Therapy Medicinal Products CDMO Market, by Indication
8.1. Introduction
8.2. Cardiology
8.3. Central Nervous System
8.4. Dermatology
8.5. Endocrine, Metabolic, Genetic
8.6. Gastroenterology
8.7. Hematology
8.8. Immunology & Inflammation
8.9. Infectious Disease
8.10. Musculoskeletal
8.11. Oncology
8.12. Ophthalmology
9. Advanced Therapy Medicinal Products CDMO Market, by End-Users
9.1. Introduction
9.2. Academic and Research Institutions
9.3. Biotechnology & Pharmaceutical Companies
9.4. Clinical Research Organizations (CROs)
9.5. Hospitals and Clinics
10. Americas Advanced Therapy Medicinal Products CDMO Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Advanced Therapy Medicinal Products CDMO Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Advanced Therapy Medicinal Products CDMO Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abzena
14.1.2. Advanced Therapies, Inc. by WuXi AppTec
14.1.3. AGC Inc.
14.1.4. Aldevron
14.1.5. Almac Group
14.1.6. Arranta Bio Holdings, LLC
14.1.7. Bio Elpida
14.1.8. BlueReg
14.1.9. Catalent Inc.
14.1.10. CELONIC Group
14.1.11. CGT Catapult
14.1.12. Charles River Laboratories International, Inc.
14.1.13. Coriolis Pharma Research GmbH
14.1.14. Eurofins Scientific SE
14.1.15. FUJIFILM Corporation
14.1.16. Lonza Group
14.1.17. Minaris Regenerative Medicine
14.1.18. Oxford Biomedica PLC
14.1.19. Patheon by Thermo Fisher Scientific Inc.
14.1.20. Rentschler Biopharma SE
14.1.21. REPROCELL Inc.
14.1.22. RoslinCT
14.1.23. Samsung Biologics
14.1.24. VIVEBIOTECH S.L.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET RESEARCH PROCESS
FIGURE 2. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, 2023 VS 2030
FIGURE 3. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET DYNAMICS
FIGURE 7. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
FIGURE 8. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 10. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 14. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 6. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY TISSUE ENGINEERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 10. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 15. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY ENDOCRINE, METABOLIC, GENETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 27. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
TABLE 30. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 44. CANADA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 45. CANADA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 46. CANADA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. CANADA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 66. CHINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 67. CHINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 68. CHINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. CHINA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 70. INDIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 71. INDIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 72. INDIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. INDIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 78. JAPAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 79. JAPAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 80. JAPAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. JAPAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. SINGAPORE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. SOUTH KOREA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. TAIWAN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 102. THAILAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 103. THAILAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 104. THAILAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. THAILAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. VIETNAM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. DENMARK ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 116. DENMARK ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 117. DENMARK ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. DENMARK ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 119. EGYPT ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 120. EGYPT ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 121. EGYPT ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. EGYPT ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 123. FINLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 124. FINLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 125. FINLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. FINLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 127. FRANCE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 128. FRANCE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 129. FRANCE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. FRANCE ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 131. GERMANY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. GERMANY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 139. ITALY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 140. ITALY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 141. ITALY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. ITALY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 151. NORWAY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 152. NORWAY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 153. NORWAY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. NORWAY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 155. POLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 156. POLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 157. POLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. POLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 159. QATAR ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 160. QATAR ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 161. QATAR ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 162. QATAR ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 175. SPAIN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 176. SPAIN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 177. SPAIN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 178. SPAIN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. SWITZERLAND ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 187. TURKEY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 188. TURKEY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 189. TURKEY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. TURKEY ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 199. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 200. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET SHARE, BY KEY PLAYER, 2023
TABLE 201. ADVANCED THERAPY MEDICINAL PRODUCTS CDMO MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abzena
  • Advanced Therapies, Inc. by WuXi AppTec
  • AGC Inc.
  • Aldevron
  • Almac Group
  • Arranta Bio Holdings, LLC
  • Bio Elpida
  • BlueReg
  • Catalent Inc.
  • CELONIC Group
  • CGT Catapult
  • Charles River Laboratories International, Inc.
  • Coriolis Pharma Research GmbH
  • Eurofins Scientific SE
  • FUJIFILM Corporation
  • Lonza Group
  • Minaris Regenerative Medicine
  • Oxford Biomedica PLC
  • Patheon by Thermo Fisher Scientific Inc.
  • Rentschler Biopharma SE
  • REPROCELL Inc.
  • RoslinCT
  • Samsung Biologics
  • VIVEBIOTECH S.L.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.74 Billion
Compound Annual Growth Rate17.0%
Regions CoveredGlobal

Related Topics

Related Reports

Global Advanced Therapy Medicinal Products CDMO Market Size, Share & Trends Analysis Report by Product (Gene Therapy, Cell Therapy), Phase, Indication, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Advanced Therapy Medicinal Products CDMO Market Size, Share & Trends Analysis Report by Product (Gene Therapy, Cell Therapy), Phase, Indication, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Global Market Report 2024 - Product Image

Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Advanced Therapy Medicinal Products CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Advanced Therapy Medicinal Products CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 184 Pages
  • Global
From
Global Advanced Therapy Medicinal Products Market Size, Share & Trends Analysis Report by Therapy Type (Cell Therapy, Gene Therapy, Tissue Engineered Product), Region (North America, Europe, APAC, ROW), and Segment Forecasts, 2023-2030 - Product Image

Global Advanced Therapy Medicinal Products Market Size, Share & Trends Analysis Report by Therapy Type (Cell Therapy, Gene Therapy, Tissue Engineered Product), Region (North America, Europe, APAC, ROW), and Segment Forecasts, 2023-2030

  • Report
  • 120 Pages
  • Global
From
Global Cell & Gene Therapy Biomanufacturing CDMO Market by Component (Cell Therapy, Plasmid DNA, Viral Vector), Phase (Phase 1, Phase 2, Phase 3), Indication - Forecast 2024-2030 - Product Image

Global Cell & Gene Therapy Biomanufacturing CDMO Market by Component (Cell Therapy, Plasmid DNA, Viral Vector), Phase (Phase 1, Phase 2, Phase 3), Indication - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From

About the Advanced Therapy CDMO Market

The Advanced Therapy CDMO market is a subset of the genomics industry that focuses on the development and manufacturing of cell and gene therapies. These therapies are used to treat a variety of diseases, including cancer, neurological disorders, and rare genetic diseases. Advanced Therapy CDMOs provide services such as process development, analytical testing, and clinical and commercial manufacturing. They also provide support for regulatory filings and clinical trials. Advanced Therapy CDMOs are an important part of the genomics industry, as they enable the development and commercialization of novel therapies. They provide the necessary infrastructure and expertise to bring these therapies to market. Some companies in the Advanced Therapy CDMO market include Lonza, Thermo Fisher Scientific, Catalent, and Fujifilm Diosynth Biotechnologies. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.